{"id":58521,"date":"2023-12-04T22:01:27","date_gmt":"2023-12-04T21:01:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/"},"modified":"2023-12-04T22:01:27","modified_gmt":"2023-12-04T21:01:27","slug":"curio-bioscience-responds-to-lawsuit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/","title":{"rendered":"Curio Bioscience Responds to Lawsuit"},"content":{"rendered":"
\n

PALO ALTO, Calif.–(BUSINESS WIRE)–Curio Bioscience is a leading innovator of high-precision tools for the life sciences industry. Our Curio Seeker product enables whole transcriptome, spatial mapping of fresh frozen tissue at industry-leading resolution and represents the next stage of innovation from our team’s inventions of the microarray, stochastic barcoding (unique molecular identifiers), and single cell and spatial tagging and analysis. Our team’s inventions of spatial localization of biological targets using barcoding were documented over 15 years ago.<\/p>\n

\nWe believe that fair competition is a key component to innovation, and we embrace the motivation that it provides for creating the newest and highest-performing products for our customers, while keeping experiment costs reasonable and pushing the frontiers of science to the greatest extent possible.<\/p>\n

\nSome companies do not share this sentiment. We have become the latest target in a string of attacks by a company (10x Genomics, NASDAQ: TXG) with a history of bringing litigation against smaller, innovating companies.<\/p>\n

\nWe are confident that we do not infringe the patents that 10x is asserting against us and believe that they will be found invalid. We will vigorously defend against 10x\u2019s allegations.<\/p>\n

Contacts<\/b> <\/p>\n

\ninfo@curiobioscience.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PALO ALTO, Calif.–(BUSINESS WIRE)–Curio Bioscience is a leading innovator of high-precision tools for the life sciences industry. Our Curio Seeker product enables whole transcriptome, spatial mapping of fresh frozen tissue at industry-leading resolution and represents the next stage of innovation from our team’s inventions of the microarray, stochastic barcoding (unique molecular identifiers), and single cell … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58521","6":"format-standard","7":"category-industry"},"yoast_head":"\nCurio Bioscience Responds to Lawsuit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curio Bioscience Responds to Lawsuit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif.–(BUSINESS WIRE)–Curio Bioscience is a leading innovator of high-precision tools for the life sciences industry. Our Curio Seeker product enables whole transcriptome, spatial mapping of fresh frozen tissue at industry-leading resolution and represents the next stage of innovation from our team’s inventions of the microarray, stochastic barcoding (unique molecular identifiers), and single cell ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-04T21:01:27+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Curio Bioscience Responds to Lawsuit\",\"datePublished\":\"2023-12-04T21:01:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/\"},\"wordCount\":202,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/\",\"name\":\"Curio Bioscience Responds to Lawsuit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-12-04T21:01:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/curio-bioscience-responds-to-lawsuit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Curio Bioscience Responds to Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Curio Bioscience Responds to Lawsuit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/","og_locale":"en_US","og_type":"article","og_title":"Curio Bioscience Responds to Lawsuit - Pharma Trend","og_description":"PALO ALTO, Calif.–(BUSINESS WIRE)–Curio Bioscience is a leading innovator of high-precision tools for the life sciences industry. Our Curio Seeker product enables whole transcriptome, spatial mapping of fresh frozen tissue at industry-leading resolution and represents the next stage of innovation from our team’s inventions of the microarray, stochastic barcoding (unique molecular identifiers), and single cell ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/","og_site_name":"Pharma Trend","article_published_time":"2023-12-04T21:01:27+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Curio Bioscience Responds to Lawsuit","datePublished":"2023-12-04T21:01:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/"},"wordCount":202,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/","url":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/","name":"Curio Bioscience Responds to Lawsuit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-12-04T21:01:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/curio-bioscience-responds-to-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Curio Bioscience Responds to Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58521"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58521\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}